Oppenheimer & Co’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,534	Closed	-$71.7K	–	1615
2025 Q1	$71.7K	Buy	22,534 +4,490	+25%	+$14.3K	﹤0.01%	1531
2024 Q4	$96.5K	Buy	18,044 +1,097	+6%	+$5.87K	﹤0.01%	1508
2024 Q3	$89.5K	Buy	+16,947	New	+$89.5K	﹤0.01%	1464